Researchers develop new drug Lenvatinib that can slow progression of Thyroid Cancer
A new thyroid cancer drug can slow the progression of the disease almost five times as compared to placebo in a new clinical trial. The new molecule, lenvatinib is a targeted therapy which deters the formation ...